How microchips could help detect prostate cancer

Professor of Electronic Engineering Andrew Flewitt is working with researchers at the Cancer Research UK (CRUK) Cambridge Centre on a more accurate PSA blood test to detect prostate cancer.

At present, the test has limitations for diagnosis and has to be sent off to central labs for the results, a process which can take up to five days. But a collaboration between the Department of Engineering and CRUK Cambridge Centre is researching the development of a new test which, it is hoped, could in future be available in GP surgeries and return immediate results.

Professor Flewitt and academic urological surgeon Mr Vincent Gnanapragasam, who co-leads the CRUK Cambridge Centre Urological Malignancies Programme, are using FBAR sensor technology in the new PSA test. FBARs are strips on a chip that measure the weight of different molecules. They can be used to measure the amount of different subtypes of PSA in a blood sample to identify more accurately whether or not the patient has – a reliable and cost-effective , using bio-sensor technology, to be delivered in a primary care setting within the goal of the next five years.

Credit: BBC Richard Westcott YouTube

Explore further

Combination of blood test and imaging improves detection of prostate cancer

Citation: How microchips could help detect prostate cancer (2018, July 16) retrieved 7 March 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments